Registered entities
CELLULAR BIOMEDICINE GROUP, INC.
Reg. No. 1378624United States
Innovation
22 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 286 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 14 |
| 2024 | 3 |
| 2025 | 2 |
Investor mix
8 investors on record; lead investors include Yunfeng Capital, AstraZeneca.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 38% |
| Private equity | 4 | 50% |
| Other / undisclosed | 1 | 13% |